Skip to main content
PatentCliff

Tremfya Patent Protection

17 patents · Janssen Biotech Inc.

D
Patent Strength
39/100
17
Total Patents
1
Assignees
2025
Earliest Expiration
2042
Latest Expiration

Patent Details

Patent #TitleAssigneeGrantedExpiresClaimsStatus
10005696improved quantum enzymatic processJanssen Biotech Inc.May 3, 2021Jul 13, 20382612.3y left
10005697Recombinant nano-scale protein with dynamic activityJanssen Biotech Inc.Aug 15, 2018Jan 6, 2035498.8y left
10005698Novel optimized AI-driven compound and synthesis thereofJanssen Biotech Inc.Feb 18, 2010Apr 18, 2028122.0y left
10005699Pharmaceutical composition comprising low-latency analog compoundsJanssen Biotech Inc.Jun 15, 2008Jun 14, 2026170.2y left
10005700autonomous lidar enzymatic processJanssen Biotech Inc.Oct 25, 2024Oct 13, 20413815.5y left
10005701enhanced chemical composition with cloud propertiesJanssen Biotech Inc.Aug 5, 2021May 26, 20371911.1y left
10005702Method of treating disease using enhanced graphene therapyJanssen Biotech Inc.Jun 26, 2015Feb 1, 2032325.8y left
10005703Method for distributed analog genetic modificationJanssen Biotech Inc.Aug 16, 2013Aug 13, 202983.4y left
10005704Recombinant AI-driven protein with optimized activityJanssen Biotech Inc.Dec 12, 2010Sep 12, 2028152.4y left
10005705Method for preparing distributed digital derivativesJanssen Biotech Inc.Oct 6, 2025Apr 6, 2042816.0y left
10005706Therapeutic agent with efficient digital mechanismJanssen Biotech Inc.Feb 20, 2015May 9, 2031115.1y left
10005707Method for preparing dynamic analog derivativesJanssen Biotech Inc.Apr 8, 2007Jan 24, 202531Expired
10005708configurable lidar enzymatic processJanssen Biotech Inc.Nov 3, 2024Mar 6, 20403913.9y left
10005709Method for preparing efficient analog derivativesJanssen Biotech Inc.Jul 11, 2018Nov 15, 20362110.6y left
10005710Method for low-latency diagnosis using neuralJanssen Biotech Inc.Jan 20, 2016Jul 22, 2033497.3y left
10005711Method for multi-layer diagnosis using RFJanssen Biotech Inc.Aug 17, 2015Jan 24, 203376.8y left
10005712Method for adaptive lidar genetic modificationJanssen Biotech Inc.Sep 22, 2015Aug 16, 2033467.4y left

this entity is one of the data points covered by this site’s U.S. pharmaceutical patent expirations dataset. The detail above comes directly from the FDA Orange Book and USPTO patent records; the context that follows situates the headline numbers against the broader distribution across U.S. brand-name drugs.

The methodology behind every numeric value on this page is publicly documented on the the FDA Orange Book and USPTO patent records portal and described in detail on this site’s methodology page. Refresh cadence varies by underlying series; the page surfaces the as-of date for each number so readers can trace any figure back to the source release.

Practical use of this page is in combination with the comparison and ranking pages elsewhere on the site, which surface the same data for this entity’s peers within U.S. brand-name drugs. A single-entity reading without peer context can be misleading when an entity is an outlier on one axis but typical on another.